IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
3
Neutral
3
Bullish
8
Bearish
23
Neutral
15
Bullish
8
Bearish
20
Neutral
12
Bullish
0
Bearish
20
Neutral
12
Bullish
0
Bearish
20
Neutral
12
Bullish
0
Bearish
20
Neutral
12
Bullish
0
Desh Rakshak Aushdhalaya Limited manufactures and sells Ayurvedic and herbal medicines, operating from Bhagwant Kuti, Kankhal, Haridwar, with a legacy dating to 1901 and a product portfolio of around 450 proprietary and classical formulations marketed under the company’s own brand suite and sold through ethical and traditional distribution channels.
The company reported standalone total revenue of Rs. 82.83 lakhs for Q1 June 2026 and Rs. 711.49 lakhs for the year ended March 31, 2026, with net profit for the year of Rs. 56.22 lakhs; Q1 2026 revenue was lower versus Q1 2025, while full year revenue grew year-on-year from Rs. 630.38 lakhs to Rs. 711.49 lakhs.
Balance sheet and equity actions: the company completed a preferential allotment in September 2025 issuing 12,60,000 equity shares at Rs.22 each and raised approximately Rs. 2.77 crore, increasing paid-up equity capital from Rs. 443.83 lakhs to Rs. 569.83 lakhs and improving reported reserves and liquidity headroom for growth or working capital.
Operational cost structure shows material consumption, employee costs and other expenses as main components; for Q1 FY2027 cost of materials was Rs.8.22 lakhs while employee benefits were Rs.22.89 lakhs, yielding a quarterly profit before tax of Rs.8.03 lakhs and indicating modest but consistent operating profitability across reporting periods.
Pharmaceuticals & Biotechnology
Pharmaceuticals
14 Cr
Low Risk
25.4
39.5
2.2
1.1
47.57
22.45
Sales CAGR
Profit CAGR
ROE
ROCE
Upcoming Result Date: Nov 13, 2026
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Investor Presentation
Q4 FY25
Desh Rakshak Aushdhalaya Ltd (DESHRAK) is currently trading at 24.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Desh Rakshak Aushdhalaya Limited manufactures and sells Ayurvedic and herbal medicines, operating from Bhagwant Kuti, Kankhal, Haridwar, with a legacy dating to 1901 and a product portfolio of around 450 proprietary and classical formulations marketed under the company’s own brand suite and sold through ethical and traditional distribution channels. The company reported standalone total revenue of Rs. 82.83 lakhs for Q1 June 2026 and Rs. 711.49 lakhs for the year ended March 31, 2026, with net profit for the year of Rs. 56.22 lakhs; Q1 2026 revenue was lower versus Q1 2025, while full year revenue grew year-on-year from Rs. 630.38 lakhs to Rs. 711.49 lakhs. Balance sheet and equity actions: the company completed a preferential allotment in September 2025 issuing 12,60,000 equity shares at Rs.22 each and raised approximately Rs. 2.77 crore, increasing paid-up equity capital from Rs. 443.83 lakhs to Rs. 569.83 lakhs and improving reported reserves and liquidity headroom for growth or working capital. Operational cost structure shows material consumption, employee costs and other expenses as main components; for Q1 FY2027 cost of materials was Rs.8.22 lakhs while employee benefits were Rs.22.89 lakhs, yielding a quarterly profit before tax of Rs.8.03 lakhs and indicating modest but consistent operating profitability across reporting periods.
Over the past 52 weeks, Desh Rakshak Aushdhalaya Ltd has traded between a low of ₹22.45 and a high of ₹47.57. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Desh Rakshak Aushdhalaya Ltd has a market capitalization of approximately 13.96. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Desh Rakshak Aushdhalaya Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 25.38 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 13.96 Cr, Desh Rakshak Aushdhalaya Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Desh Rakshak Aushdhalaya Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Desh Rakshak Aushdhalaya Ltd is 25.38. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
106.50 | 16 Cr | -79.90 | 12.80 | 0.00 | -15.95 | -15.74 | -10.93 | ||
36.00 | 15 Cr | 4.15 | 0.76 | 0.00 | 20.15 | 30.12 | 10.11 | ||
38.00 | 15 Cr | 9.49 | 0.88 | 0.00 | 9.36 | 11.66 | 3.86 | ||
24.50 | 14 Cr | 25.38 | 1.07 | 0.00 | 4.23 | 5.80 | 2.63 | ||
25.34 | 13 Cr | 20.73 | 1.30 | 0.00 | 4.30 | 7.56 | 4.14 | ||
28.25 | 13 Cr | 74.47 | 2.81 | 0.00 | 3.63 | 9.31 | 2.70 | ||
14.49 | 12 Cr | -17.58 | 9.52 | 0.00 | -59.85 | -32.17 | -19.35 | ||
| Median: 7 Co. | — | 28.25 | 14 Cr | 9.49 | 1.30 | 0.00 | 4.23 | 7.56 | 2.70 |
